After standard therapy failed, Thomas Bland's doctor turned to a form of immunotherapy known as a checkpoint inhibitor. Now, Mr. Bland is the first stage 4 sarcomatoid kidney cancer patient to be cured of the disease, and his case was reported in the American Society of Clinical Oncology's Journal of Oncology Practice.
